Laboratory Equipment Market Set for Steady Growth to USD 96.1 Billion by 2031, Led by North America's 38% Market Share | Key Players - Thermo Fisher Scientific, Danaher, Agilent Technologies

Leander Texas -
The global Laboratory equipment market reached US$ 53.1 billion in 2023 and is expected to reach US$ 96.1 billion by 2031, growing at a CAGR of 7.7% during the forecast period 2024-2031.

The market's strong growth is fueled by rising R&D investments and advanced automation adoption in the U.S. healthcare and biotech sectors, alongside strategic expansions and technology partnerships by major lab equipment firms in Japan, which are enhancing precision diagnostics and analytical capabilities.

Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/laboratory-equipment-market?prtk

Key Industry Development

United States
✅ December 2025: Thermo Fisher Scientific expanded its laboratory automation portfolio with AI-integrated mass spectrometers, enhancing proteomics workflows and boosting throughput by 25% for biopharma R&D labs nationwide.

✅ November 2025: Agilent Technologies launched the Dako Omnis 165 Duo tissue staining system, improving precision in cancer diagnostics and enabling high-volume pathology labs to process 40% more samples daily.

✅ October 2025: Danaher Corporation introduced AI-powered liquid handling robots under Beckman Coulter branding, reducing manual errors by 20% and accelerating drug discovery pipelines in U.S. research facilities.

✅ September 2025: PerkinElmer unveiled advanced chromatography systems with real-time data analytics, supporting personalized medicine initiatives and increasing adoption in biotech hubs like Boston and San Francisco.

Japan
✅ November 2025: Shimadzu Corporation released a next-gen gas chromatograph-mass spectrometer hybrid, optimizing environmental testing labs for faster pollutant detection amid stricter regulations.

✅ October 2025: Hitachi High-Tech launched automated microscopy platforms for semiconductor labs, improving nanoscale imaging resolution by 15% to support Japan's precision manufacturing sector.

✅ September 2025: Eppendorf Japan partnered with local pharma firms to deploy modular thermal cyclers, enhancing PCR efficiency in gene therapy research and aligning with rising biotech investments.

Strategic Mergers and Acquisitions:

In July 2025, Waters Corporation agreed to merge with the Biosciences & Diagnostic Solutions business of Becton, Dickinson and Company in a transaction valued at USD 17.5 billion. This Reverse Morris Trust deal involves BD spinning off the business and merging it with Waters, significantly expanding Waters' laboratory instruments and diagnostic footprint, particularly in life sciences research tools and clinical diagnostics, while increasing recurring revenue and total addressable market. The transaction is expected to close in Q1 2026.

In November 2025, Abbott Laboratories announced its definitive agreement to acquire Exact Sciences Corporation for approximately USD 21 billion, representing one of the largest deals of the year in diagnostics and laboratory technology. This acquisition is poised to broaden Abbott's diagnostic capabilities, particularly in cancer detection tools and precision oncology platforms, and significantly expand its role in laboratory testing markets globally.

In December 2025, The Tecan Group completed the acquisition of select assets from Wako Automation, including advanced laboratory automation software and hardware modules. This strategic purchase enhances Tecan's automation portfolio, particularly in liquid‐handling and complex workflow orchestration, strengthening its competitive position in automated laboratory systems.

In November 2025, Semilab finalized the acquisition of Bristol Nano Dynamics Ltd. (BND), a UK‐based developer of nanoscale surface characterization instruments. This move expands Semilab's analytical equipment lineup in high‐resolution surface science tools used in material research and semiconductor metrology.

Major Players:-
Thermo Fisher Scientific Inc. | Agilent Technologies, Inc. | BD | Beckman Coulter, Inc. | Bio-Rad Laboratories, Inc. | Bruker | Eppendorf SE | F. Hoffmann-La Roche Ltd | PerkinElmer Inc. | Shimadzu Corporation

1. Thermo Fisher Scientific Inc. - Thermo Fisher leads the global laboratory equipment market with an 18% share, offering the broadest portfolio of analytical instruments, reagents, consumables and digital lab solutions. Its strength lies in high‐end mass spectrometry, chromatography and integrated workflows for life sciences, diagnostics and biopharma research.

2. Agilent Technologies, Inc. - Holding around 3% of the market, Agilent excels in analytical and chemical measurement instruments like chromatography and spectroscopy systems. Its advanced precision tools and services for pharmaceutical, environmental, food testing and research labs support high‐quality data and robust workflows.

3. Becton, Dickinson and Company (BD) - BD's strength stems from clinical lab automation, flow cytometry and specimen management systems that improve throughput and accuracy. While specific total lab equipment market share is smaller than the top leaders, BD's solutions are essential in diagnostics, clinical workflows and sample preparation.

4. Beckman Coulter, Inc. - As part of larger science portfolios, Beckman Coulter contributes key automated analyzers and life science instrumentation, especially in clinical diagnostics and cell analysis. Its high‐performance clinical chemistry and immunoassay systems make it vital in hospital and diagnostic laboratory settings.

5. Bio‐Rad Laboratories, Inc. - With about a 5.4% share, Bio‐Rad specializes in life science research tools such as PCR systems, electrophoresis and digital PCR platforms. Its strength lies in molecular biology and genomics research, helping researchers amplify, quantify and analyze genetic material efficiently.

"Secure your 30% discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=laboratory-equipment-market?prtk (Purchase 2 or more Repots and get 50% Discount)

Market Segmenatation-

1. Equipment Type Segmentation: The laboratory equipment market in both the United States and Japan is commonly divided by equipment type such as general, analytical, clinical, support, and specialty instruments. In the U.S., the general equipment segment was the largest revenue generator in 2023 with significant adoption across research, diagnostics, and industrial labs, supported by strong demand for automated and precision tools. In Japan, general equipment also led the market in 2023, but support equipment (like maintenance and auxiliary systems) showed the fastest growth as laboratories modernize for higher productivity and regulatory compliance.

2. Product/Application Segmentation: Within equipment categories, products are further split into analytical (spectrometers, chromatographs), clinical diagnostic machines, and specialty devices. In the U.S., analytical and clinical segments are strong due to heavy investment in healthcare and biotech R&D which drives demand for high‐throughput and precision analysis systems. Japan's segmentation similarly includes analytical and specialty instruments, with analytical tools particularly in demand as regulatory acceleration of drug approvals and advanced bioanalysis require sophisticated measurement technologies.

3. End‐User Segmentation: Both markets categorize end users into pharmaceuticals & biotechnology companies, clinical and diagnostic laboratories, academic research institutes, and industrial labs. In the U.S., the pharmaceutical and biotech sector dominates equipment purchases due to large R&D spending and clinical research activities. In Japan, end users like clinical labs and academic research institutions also drive equipment demand, but an aging population and expanded clinical trials contribute to sustained growth across these segments.

Market Drivers:

• Strong Expansion of R&D and Life Sciences Spending: The United States dominates the laboratory equipment landscape due to extensive investments in pharmaceutical, biotech, clinical research, and diagnostics. Federal research budgets such as from the NIH drive demand for advanced lab instruments.

• Increasing Adoption of Automation and Digital Solutions: U.S. laboratories are rapidly integrating automation platforms, AI‐enabled analytics, and digital workflows to improve throughput and data accuracy, supporting high‐complexity testing and large‐scale operations.

• Regulatory Compliance and Quality Assurance Pressure: Compliance with strict FDA standards and quality management protocols increases demand for precise, high‐performance laboratory equipment capable of meeting rigorous regulatory validation requirements across clinical and industrial labs.

• Growth in Pharmaceutical and Biotech R&D Pipelines: Intensifying drug discovery programs, biologics development, and personalized medicine initiatives are expanding demand for analytical and life‐science laboratory instruments across research and production stages.

• Integration of Smart and Modular Lab Technologies: Scalable analytical systems that offer flexibility, connectivity, and minimal manual intervention are gaining ground, driven by the need for efficient workflows in both academic and commercial settings.

Regional insights:

North America: 38% (Largest share - driven by advanced R&D, healthcare diagnostics, and strong US laboratory infrastructure; the United States leads the region with the majority of demand)

Asia Pacific: 30% (Fast‐growing region - supported by expansion in China, India, and Japan; Japan accounts for about 6.2% of the global laboratory equipment market with robust precision instrument adoption)

Europe: 25% (Steady demand - mature healthcare systems and stringent regulatory standards drive adoption of advanced laboratory equipment)

Japan (Asia Pacific sub‐segment): 6.2% (Standalone national share - Japan's laboratory equipment market contributes roughly 6.2% to the total global market, reflecting strong institutional demand)

United States (within North America): approx. 69% of regional share (the US dominates the North American laboratory equipment market, reflecting about 69.3% of the total regional revenue due to heavy biotech/diagnostics investment)

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/laboratory-equipment-market?prtk

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.